Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 1/2006

01.01.2006 | Clinical Investigation

Ocular manifestations in congenital toxoplasmosis

verfasst von: Laurent Kodjikian, Martine Wallon, Jacques Fleury, Philippe Denis, Christine Binquet, François Peyron, Justus G. Garweg

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 1/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

Retinochoroiditis is the most common ocular manifestation of congenital toxoplasmosis, but other associated ophthalmological pathologies can also occur. The aim of this study was to determine the nature of the latter in treated cases of the disease and to assess their impact on visual function.

Methods

Four hundred and thirty consecutive children with serologically confirmed congenital toxoplasmosis were included in this study. Data were prospectively collected using standardized ophthalmological assessment forms. The presence of retinochoroiditis and of associated pathologies was ascertained, and their impact on visual function was assessed.

Results

After a median follow-up of 12 years [range 0.6–26 years], 130 children manifested retinochoroiditis. We detected 22 foci of retinochoroiditis at birth and 264 additional ones during the follow-up period. Of these, 48 (17%) were active when first diagnosed. Twenty-five of the 130 children (19%) had other associated ocular pathologies. Of these, 21 (16%) had a strabismus, which was due to macular lesions in 86% of the cases; 7 (5.4%) presented with unilateral microphthalmia, and 4 (3%) with cataracts. Most of these events were detected after the onset of retinochoroiditis. None of the children presented with ocular involvement in the absence of chorioretinal lesions. Macular lesions occurred more frequently in children with associated pathologies (p<0.0001), and associated pathologies were likewise more common in individuals with macular lesions (p=0.0003). Visual impairment occurred in 31/130 cases, and in all but 3 of these eyes it was due not to an associated pathology but to macular retinochoroiditis.

Conclusions

At the end of the follow-up period, ocular involvement existed in 30% of the treated children with congenital toxoplasmosis. Associated eye pathologies were manifested less frequently than anticipated. They may occur later in life and are an indirect marker of the severity of congenital toxoplasmosis, but they do not have a direct impact on visual acuity. The overall functional prognosis of congenital toxoplasmosis is better than would be expected on the basis of literature findings, with only 2 of the 130 children suffering bilateral visual impairment.
Literatur
1.
Zurück zum Zitat Binquet C, Wallon M, Quantin C, Kodjikian L, Garweg J, Fleury J, Peyron F, Abrahamowicz M (2003) Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect 131:1157–1168CrossRefPubMed Binquet C, Wallon M, Quantin C, Kodjikian L, Garweg J, Fleury J, Peyron F, Abrahamowicz M (2003) Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect 131:1157–1168CrossRefPubMed
3.
Zurück zum Zitat de Jong PT (1989) Ocular toxoplasmosis: common and rare symptoms and signs. Int Ophthalmol 13:391–397PubMedCrossRef de Jong PT (1989) Ocular toxoplasmosis: common and rare symptoms and signs. Int Ophthalmol 13:391–397PubMedCrossRef
4.
Zurück zum Zitat Fahnehjelm KT, Malm G, Ygge J, Engman ML, Maly E, Evengard B (2000) Ophthalmological findings in children with congenital toxoplasmosis. Report from a Swedish prospective screening study of congenital toxoplasmosis with two years of follow-up. Acta Ophthalmol Scand 78:569–575CrossRefPubMed Fahnehjelm KT, Malm G, Ygge J, Engman ML, Maly E, Evengard B (2000) Ophthalmological findings in children with congenital toxoplasmosis. Report from a Swedish prospective screening study of congenital toxoplasmosis with two years of follow-up. Acta Ophthalmol Scand 78:569–575CrossRefPubMed
5.
Zurück zum Zitat Folk JC, Lobes LA (1984) Presumed toxoplasmic papillitis. Ophthalmology 91:64–67PubMed Folk JC, Lobes LA (1984) Presumed toxoplasmic papillitis. Ophthalmology 91:64–67PubMed
6.
Zurück zum Zitat Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, Jenum PA, Hedman K, Naessens A (1999) Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children’s sequelae at age 1 year. Am J Obstet Gynecol 180:410–415PubMedCrossRef Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, Jenum PA, Hedman K, Naessens A (1999) Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children’s sequelae at age 1 year. Am J Obstet Gynecol 180:410–415PubMedCrossRef
7.
Zurück zum Zitat Frau E, Gregoire-Cassoux N, Lautier-Frau M, Labetoulle M, Lehoang P, Offret H (1997) Toxoplasmic chorioretinitis complicated by retinal detachment. J Fr Ophtalmol 20:749–752PubMed Frau E, Gregoire-Cassoux N, Lautier-Frau M, Labetoulle M, Lehoang P, Offret H (1997) Toxoplasmic chorioretinitis complicated by retinal detachment. J Fr Ophtalmol 20:749–752PubMed
8.
Zurück zum Zitat Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H (1986) Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1:254–625CrossRefPubMed Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H (1986) Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1:254–625CrossRefPubMed
9.
Zurück zum Zitat Kvarnstrom G, Jakobsson P, Lennerstrand G (1998) Screening for visual and ocular disorders in children, evaluation of the system in Sweden. Acta Paediatr 87:1173–1179CrossRefPubMed Kvarnstrom G, Jakobsson P, Lennerstrand G (1998) Screening for visual and ocular disorders in children, evaluation of the system in Sweden. Acta Paediatr 87:1173–1179CrossRefPubMed
10.
Zurück zum Zitat Kvarnstrom G, Jakobsson P, Lennerstrand G (2001) Visual screening of Swedish children: an ophthalmological evaluation. Acta Ophthalmol Scand 79:240–244CrossRefPubMed Kvarnstrom G, Jakobsson P, Lennerstrand G (2001) Visual screening of Swedish children: an ophthalmological evaluation. Acta Ophthalmol Scand 79:240–244CrossRefPubMed
11.
Zurück zum Zitat Meenken C, Assies J, van Nieuwenhuizen O, Holwerda-van der Maat WG, van Schooneveld MJ, Delleman WJ, Kinds G, Rothova A (1995) Long term ocular and neurological involvement in severe congenital toxoplasmosis. Br J Ophthalmol 79:581–584PubMedCrossRef Meenken C, Assies J, van Nieuwenhuizen O, Holwerda-van der Maat WG, van Schooneveld MJ, Delleman WJ, Kinds G, Rothova A (1995) Long term ocular and neurological involvement in severe congenital toxoplasmosis. Br J Ophthalmol 79:581–584PubMedCrossRef
12.
Zurück zum Zitat Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, Stein M, Hopkins J, Withers S, Mack D, Luciano R, Patel D, Remington JS, Meier P, McLeod R (1996) Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 122:309–324PubMed Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, Stein M, Hopkins J, Withers S, Mack D, Luciano R, Patel D, Remington JS, Meier P, McLeod R (1996) Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 122:309–324PubMed
13.
Zurück zum Zitat Preslan M, Novak A (1996) Baltimore vision screening project. Ophthalmology 103:105–109PubMed Preslan M, Novak A (1996) Baltimore vision screening project. Ophthalmology 103:105–109PubMed
14.
Zurück zum Zitat Roberts T, Frenkel JK (1990) Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. J Am Vet Med Assoc 196:249–256PubMed Roberts T, Frenkel JK (1990) Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. J Am Vet Med Assoc 196:249–256PubMed
15.
Zurück zum Zitat Rose GE (1991) Papillitis, retinal neovascularisation and recurrent retinal vein occlusion in Toxoplasma retinochoroiditis: a case report with uncommon clinical signs. Aust N Z j Ophthalmol 19:155–157PubMedCrossRef Rose GE (1991) Papillitis, retinal neovascularisation and recurrent retinal vein occlusion in Toxoplasma retinochoroiditis: a case report with uncommon clinical signs. Aust N Z j Ophthalmol 19:155–157PubMedCrossRef
16.
Zurück zum Zitat Sabates R, Pruett RC, Brockhurst RJ (1981) Fulminant ocular toxoplasmosis. Am J Ophthalmol 92:497–503PubMed Sabates R, Pruett RC, Brockhurst RJ (1981) Fulminant ocular toxoplasmosis. Am J Ophthalmol 92:497–503PubMed
17.
Zurück zum Zitat Song A, Scott IU, Davis JL, Lam BL (2002) Atypical anterior optic neuropathy caused by toxoplasmosis. Am J Ophthalmol 133:162–164CrossRefPubMed Song A, Scott IU, Davis JL, Lam BL (2002) Atypical anterior optic neuropathy caused by toxoplasmosis. Am J Ophthalmol 133:162–164CrossRefPubMed
18.
Zurück zum Zitat Vutova K, Peicheva Z, Popova A, Markova V, Mincheva N, Todorov T (2002) Congenital toxoplasmosis: eye manifestations in infants and children. Ann Trop Paediatr 22:213–218CrossRefPubMed Vutova K, Peicheva Z, Popova A, Markova V, Mincheva N, Todorov T (2002) Congenital toxoplasmosis: eye manifestations in infants and children. Ann Trop Paediatr 22:213–218CrossRefPubMed
19.
Zurück zum Zitat Wallon M, Dunn D, Slimani D, Girault V, Gay-Andrieu F, Peyron F (1999) Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA? Eur J Pediatr 158:645–649CrossRefPubMed Wallon M, Dunn D, Slimani D, Girault V, Gay-Andrieu F, Peyron F (1999) Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA? Eur J Pediatr 158:645–649CrossRefPubMed
20.
Zurück zum Zitat Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C, Peyron F (2004) Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113:1567–1572CrossRefPubMed Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C, Peyron F (2004) Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113:1567–1572CrossRefPubMed
21.
Zurück zum Zitat Willerson D Jr, Aaberg TM, Reeser F, Meredith TA (1977) Unusual ocular presentation of acute toxoplasmosis. Br J Ophthalmol 61:693–698PubMedCrossRef Willerson D Jr, Aaberg TM, Reeser F, Meredith TA (1977) Unusual ocular presentation of acute toxoplasmosis. Br J Ophthalmol 61:693–698PubMedCrossRef
Metadaten
Titel
Ocular manifestations in congenital toxoplasmosis
verfasst von
Laurent Kodjikian
Martine Wallon
Jacques Fleury
Philippe Denis
Christine Binquet
François Peyron
Justus G. Garweg
Publikationsdatum
01.01.2006
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 1/2006
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-005-1164-3

Weitere Artikel der Ausgabe 1/2006

Graefe's Archive for Clinical and Experimental Ophthalmology 1/2006 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.